Skip to Main Content

Author Details

Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1966
461
106
PMIDPaper TitleJournal TitlePublished Year
37020550Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants.Front Immunol2023
37624046CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18.J Immunol2023
35128358BepiTBR: T-B reciprocity enhances B cell epitope prediction.iScience2022
35474866MPA<sub>PASS</sub> software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays.Cell Rep Methods2022
35873792An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques.PNAS Nexus2022
36055226Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD.Cancer Cell2022
33232788Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.Cancer Lett2021
36524208The role of NKT cells in gastrointestinal cancers.Oncoimmunology2021
33908897Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.JCI Insight2021
33573221Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization.Pathogens2021
33544111A simple, high-throughput method of protein and label removal from extracellular vesicle samples.Nanoscale2021
33732259The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination.Front Immunol2021
34976830Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.Front Oncol2021
34910932Thomas Alexander Waldmann.Immunity2021
34960230Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals.Vaccines (Basel)2021
34603318IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.Front Immunol2021
34149696SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.Front Immunol2021
33367885Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.Neuro Oncol2021
32184782Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development.Front Immunol2020
31948558Complementary approaches to study NKT cells in cancer.Methods Enzymol2020
33142797High Sensitivity Protein Gel Electrophoresis Label Compatible with Mass-Spectrometry.Biosensors (Basel)2020
32796024Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity.J Immunol2020
32420917Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.J Clin Invest2020
32219267Synthetic preparation and immunological evaluation of β-mannosylceramide and related N-acyl analogues.Org Biomol Chem2020
30277831The effect of antigen dose on T cell-targeting vaccine outcome.Hum Vaccin Immunother2019
31646070Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory.Oncoimmunology2019
31649670Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.Front Immunol2019
31258878High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.J Extracell Vesicles2019
31620124Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.Front Immunol2019
31131086Strategies for developing and optimizing cancer vaccines.F1000Res2019
30776026Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response.J Clin Invest2019
31139193Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate.Front Immunol2019
30818341Interleukin 21 collaborates with interferon-γ for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection.PLoS Pathog2019
29143114Cancer vaccine strategies: translation from mice to human clinical trials.Cancer Immunol Immunother2018
30158927Tissue-Specific Roles of NKT Cells in Tumor Immunity.Front Immunol2018
29858581Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques.Mucosal Immunol2018
30071576Prospective Use of High-Refractive Index Materials for Single Molecule Detection in Flow Cytometry.Sensors (Basel)2018
29900040Differential Regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin.Oncoimmunology2018
29554495Cancer vaccines: translation from mice to human clinical trials.Curr Opin Immunol2018
29520281Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.Front Immunol2018
29374075Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.J Immunol2018
29655599Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells.Cytotherapy2018
29798856Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.Science2018
29677387IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF<sup>+</sup> innate T cells in the human liver.Eur J Immunol2018
28073842Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients.Clin Cancer Res2017
28498847Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.PLoS Pathog2017
28348274Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.J Immunol2017
28500324Labeling Extracellular Vesicles for Nanoscale Flow Cytometry.Sci Rep2017
29079845Glycolipid-peptide conjugate vaccines enhance CD8<sup>+</sup> T cell responses against human viral proteins.Sci Rep2017
28951425Differential T cell homing to colon vs. small intestine is imprinted by local CD11c<sup>+</sup> APCs that determine homing receptors.J Leukoc Biol2017
  • 1 - 50 of 461

Recommended Authors

Michele A Kutzler
Drexel University College of Medicine
Career Start Year 2004
Number of shared co-authors 3
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
Glenda Canderan
University of Virginia
Career Start Year 2003
Number of shared co-authors 1
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 5
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
William D Martin
EpiVax Inc.
Career Start Year 2001
Number of shared co-authors 4
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 3
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 1
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 1
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 10
Deborah Palliser
Albert Einstein College of Medicine
Career Start Year 1992
Number of shared co-authors 2
Leonard Moise
EpiVax Inc.
Career Start Year 1991
Number of shared co-authors 4
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 9
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 5
William H Hildebrand
University of Oklahoma Health Sciences Center
Career Start Year 1990
Number of shared co-authors 5
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 3
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Career Start Year 1989
Number of shared co-authors 3
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 1
Kanury V S Rao
Translational Health Science and Technology Institute
Career Start Year 1987
Number of shared co-authors 0
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 1
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 12
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 2
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 3
Gerald T Nepom
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 4
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 2
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 0
Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 1
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 1

Collaborators

Masaki Terabe
National Cancer Institute
Co-authored papers 74
Gene M Shearer
Co-authored papers 29
Charles DeLisi
Co-authored papers 15
Amiran Dzutsev
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 14
Blake Frey
University of Alabama at Birmingham
Co-authored papers 12
Ligia A Pinto
Frederick National Laboratory for Cancer Research
Co-authored papers 10
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 10
Stephen L Hoffman
Inc., 9800 Medical Center Drive
Co-authored papers 9
Lee J Helman
Osteosarcoma Institute
Co-authored papers 8
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 7
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 6
Anne S De Groot
University of Georgia
Co-authored papers 6
Jennifer C Jones
Co-authored papers 6
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Huifeng Yu
Co-authored papers 5
Joshua A Welsh
Co-authored papers 5
John L Spouge
Co-authored papers 4
John T Schiller
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Vladimir A Kuznetsov
Co-authored papers 4
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Donald S Burke
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Co-authored papers 4
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Marcin Moniuszko
Medical University of Bialystok
Co-authored papers 4
Victor H Engelhard
University of Virginia School of Medicine
Co-authored papers 4
William Marston Linehan
Co-authored papers 3
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 3
Douglas R Lowy
Co-authored papers 3
David C Montefiori
Co-authored papers 3
David I Watkins
Co-authored papers 3
Release 1.2